First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers.

Mackie A, Rascher J, Schmid M, Endriss V, Brand T, Seibold W

Open source

DOI
10.1183/23120541.00447-2020
Published
2021 Jan
Container
ERJ open research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1183/23120541.00447-2020,
  title = {First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers.},
  author = {Mackie A and Rascher J and Schmid M and Endriss V and Brand T and Seibold W},
  year = {2021},
  journal = {ERJ open research},
  doi = {10.1183/23120541.00447-2020},
  url = {https://doi.org/10.1183/23120541.00447-2020}
}

RIS

TY  - JOUR
TI  - First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers.
AU  - Mackie A
AU  - Rascher J
AU  - Schmid M
AU  - Endriss V
AU  - Brand T
AU  - Seibold W
PY  - 2021
JO  - ERJ open research
DO  - 10.1183/23120541.00447-2020
UR  - https://doi.org/10.1183/23120541.00447-2020
ER  - 

APA

A, M., J, R., M, S., V, E., T, B., & W, S. (2021). First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers.. ERJ open research. https://doi.org/10.1183/23120541.00447-2020

Source records